Long-time US healthcare reform advocates Elijah Cummings and Bernie Sanders have written letters to several drugmakers in an effort to breathe new life into a 2014 investigation into generic price fixing.
Congressman Cummings, Chair of the House Oversight Committee, and Senator Sanders, a presidential candidate and advocate of “Medicare for all,” have demanded answers from Teva Pharmaceutical (NYSE: TEVA), Mylan (Nasdaq: MYL) and Heritage Pharmaceuticals.
The letters are aimed at renewing a probe into alleged price coordination, which saw the prices of some pharmaceutical products rise by over 8,000% between October 2013 and April 2014.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze